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Abstract 
Purpose: To investigate the phytochemical profile and antihyperplasic effect of ethanol extract of 
Fructus hordei. G (FHE) on hyperplasia of mammary gland (HMG) in rats. 
Methods: The Fructus hordei. G extract (FHE) was obtained by a rotary vacuum evaporator. The total 
flavonoids, total alkaloids and total phenolic compounds in FHE were assayed by aluminum chloride 
colorimetric method, acid-dye colorimetry and Folin-Ciocalteu method, respectively. HMG model rats 
were prepared for the experiments by injecting estradiol and progesterone. After oral administration with 
150, 300 and 600 mg/kg of FHE for 30 days, breast nipple height, and serum superoxide dismutase 
(SOD), glutathione peroxidase (GSH-Px), malondialdehyde (MDA), 5-hydroxytryptamine (5-HT), 
estradiol (E2), progesterone (P), prolactin (PRL), follicle stimulating hormone (FSH), luteinizing hormone 
(LH) and gonadotropin-releasing hormone (GnRH) levels of the rats were measured by ELISA kits. The 
pathological morphology of mammary gland tissues was examined by optical microscopy.  
Results: The ethanol extract of FHE contained 1.88 ± 0.05 mg total flavonoids/g as quercetin 
equivalent (QE), 21.93 ± 0.06 mg hordenine equivalent (HE) of total alkaloids/g extract and 70.64 ± 0.11 
mg total phenols/g gallic acid equivalent (GAE). The extract significantly diminished breast nipple 
height, MDA, 5-HT, E2, PRL, FSH and GnRH levels, and increased SOD, GSH-Px, P and LH levels (p < 
0.05). FHE inhibited the alveolus, lobules and secretion of the mammary gland. 
Conclusion: Fructus hordei extract has significant antihyperplasia effect on mice mammary gland by 
regulating serum sex hormones. 
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Hyperplasia of mammary gland (HMG) is a kind 
of pathological hyperplasia of the lobules of the 
mammary gland induced by balance disorder of 
estrogen and progesterone [1]. HMG is related to 
occupation, abuse of sex hormone drugs, diet 
and mental pressure [2,3]. The number of 
patients with HMG has increased in recent years 
[4] and it has severe cancerous tendencies such 
as early breast cancer [5]. 
 
Chemical drugs are used in treating HMG, but 
they always cause several side effects such as 
menstrual disorder, and the relapse rate is very 
high. Hormonal drugs such as progesterone or 
testosterone propionate can reduce estrogen 
required to regulate the balance of hormone for 
curing HMG [6]. Tan [7] found that tamoxifen can 
significantly relieve the symptoms of HMG, but it 
still brought about some side effects such as 
gastrointestinal reaction, vomit or diarrhea, 
menstrual disorder, neuropsychiatric symptoms, 
headache or vertigo. Hence, patients often seek 
Chen & Li 
Trop J Pharm Res, May 2015; 14(5):   
 
790 
herbal therapies outside of orthodox medical 
approaches. 
 
Fructus hordei G. is a type of herb widely used in 
China. In the ancient book, “Zhonghuazi” of Song 
Dynasty, it was claimed to have been used to 
treat hyperplasia of mammary gland effectively 
[8]. It has the effect of regulating endocrine 
disorder and is usually used for the treatment of 
HMG [9,10]. In this study, we explored the effects 
of Fructus hordei G. extract (FHE) on HMG in 
rats. It has been reported that flavonoids, 
alkaloids and phenolics are the main 
components of Fructus hordei G. [11], but the 
contents are not known. In this study, 
phytochemical compositions and antihyperplasic 






Fructus hordei G was collected from Bozhou 
City, Anhui Province in China in July 2013. 
Taxonomic identification of the plant was 
performed by Prof Jin-qiu Wang of Shandong 
University of Traditional Chinese Medicine in 
China. A voucher specimen (no. FHG 
201309552) was deposited in the College of 
Pharmacy, Shandong University of Traditional 
Chinese Medicine, China for future reference. 
The powdered sample was placed in a thimble in 
a Soxhlet apparatus and extracted exhaustively 
with 50 % ethanol (1:40, w:v) at 60 °C for 2 h. 
The extract was filtered through Whatman filter 
paper no. 1 and the filtrate concentrated under 
reduced pressure at 55 °C using a rotary vacuum 
evaporator. The concentrated extract was then 
evaporated on a boiling water bath until a 
constant weight was obtained. The dried extract 
was weighed, the yield noted and kept in an air-
tight container protected from light until used. 
 
Other drugs and reagents used were 
Tamoxifen® tablets (Ningbo Tianheng 
Pharmaceutical Co. Ltd, China). E2, P, PRL, 
FSH, LH, GnRH, MDA, SOD, GSH-Px and 5-HT 
ELISA kits, and were obtained from Nanjing 
Jiancheng Institute of Bioengineering, Nanjing, 
China. 
 
Determination of total flavonoids 
 
Total flavonoids were analyzed using aluminum 
chloride colorimetric method [12]. FHE sample 
(600 μL ,600 μg/mL) was mixed with 600 μL of 2 
% aluminum chloride solution. The mixture was 
allowed to stand at room temperature (27 ± 2 °C) 
for 10 min with intermittent shaking. The 
absorbance of the mixture was measured at 415 
nm against a blank sample (methanol) without 
aluminum chloride using a UV-Vis 
spectrophotometer (SHIMADZU, Japan). The 
total flavonoids content was determined using a 
standard curve of quercetin (0.4–15.8 μg/mL). 
The content was expressed as mg quercetin 
equivalent/g of dry extract. 
 
Determination of total alkaloids 
 
Total alkaloids were determined using acid dye 
colorimetry method [13]. The sample (1.0 mL, 
600 μg/mL) or standard hordenine ethanol 
solution (10 - 80 μg/mL) was mixed with 
phosphate buffer (2.0 mL, pH = 7), bromothymol 
blue solution (1.0 mL, 1 % w/v) and chloroform 
(3.0 mL). The mixture was allowed to stand at 
room temperature (27 ± 2 °C) for 1 min with 
shaking, then static for 60 min. The chloroform 
layer was obtained. The absorbance of the 
mixture was measured at 284 nm using a UV-Vis 
spectrophotometer (Shimadzu, Japan). The 
content of total alkaloid compounds was 
expressed as mg hordenine equivalent/g of dry 
extract. 
 
Content determination of total phenolics 
 
Total phenolics were determined using Folin-
Ciocalteu procedure. The sample (300 μg / mL) 
or standard gallic acid solution (10-120 μg / mL), 
0.4 mL was mixed with the Folin-Ciocalteu 
reagent (1.0 mL ,diluted 1:10 with deionized 
water) and  sodium bicarbonate solution (1.6 mL, 
8.0 % w/v). The mixture was allowed to stand at 
room temperature (27 ± 2 °C) for 30 min with 
intermittent shaking. The absorbance of the 
mixture was measured at 765 nm using a UV-Vis 
spectrophotometer (SHIMADZU, Japan). The 
content of total phenolic compounds was 
expressed as mg gallic acid equivalent/g of dry 
extract. 
 
Animals and model preparation 
 
Female Wistar rats, weighing 200 - 240 g, were 
obtained from Shandong Center for Disease 
Control and Prevention, Jinan, Shandong 
(certificate number SYXF 2002-0008). The 
animals had free access to rat feed and water, 
and were allowed to acclimatize for at least one 
week before use. The rat experiments were 
approved by the Animal Care and Use 
Committee of Shandong Tumor Hospital 
(Approval reference no. 20130827) and was 
carried out in compliance with the Directive 
2010/63/EU on the handling of animals used for 
scientific purposes [14]. 
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Estradiol (0.5 mg/kg) was injected in the thigh 
muscle of the rats once every day for 25 days, 
then 5 mg/kg progesterone was injected once 
every day consecutively for 5 days. In this way, 
the HMG model rat was prepared [15,16]. All rats 
were randomly assigned to six groups of ten rats: 
sham group, model group, tamoxifen group (1.65 
mg/kg), and FHE (150, 300 and 600 mg/kg) 
groups. The rats were orally administrated with 
the corresponding drugs once a day. Distilled 
water was administered in the same manner for 
the sham-operated and model control groups. 
Treatment started from the next day after the 
model preparation and continued for 4 weeks. 
 
Measurement of nipple height and 
biochemical parameters 
 
After 4 weeks of administration, the nipple height 
of the rats were measured using a vernier 
caliper. Serum MDA, GSH-Px and 5-HT of rats 
were measured by detection kits according to the 
procedures recommended by the manufacturer 
(Nanjing Jiancheng Co. Ltd), and serum SOD 
was measured by spectrophotometric method. 
 
At the same time, serum E2, P, PRL, FSH, LH 
and GnRH of rats were measured by ELISA kits 





Tissues of mammary gland from each group 
were fixed in 10 % buffered formalin, embedded 
in paraffin, sectioned into 4µm thickness, stained 
with hematoxylineosin (H-E) and Masson-
Trichrome (M-T) and examined using optical 
microscope. The severity of mammary gland 
hyperplasia was based on four parameters 
(hyperplasia of gland alveolus, lobule, shape and 




All values are expressed as mean ± SEM. 
Multiple group comparisons were performed 
using one-way analysis of variance (ANOVA) 
with the aid of SPSS 18.0 software, followed by 
Dunnett’s test to detect inter-group differences. P 




Total flavonoids, alkaloids and phenolic 
contents of FHE 
 
Extract yield, total flavonoids, total alkaloids and 
total phenolic contents of the 50 % ethanol 
extract of Fructus hordei G are shown in Table 1. 
Table 1: Yield, total flavonoids, total alkaloids and total 




Crude extract (% dry weight) 37.24 ± 0.05 
Total flavonoid content (mg QE/g) 1.88 ± 0.05 
Total alkaloid content (mg HE/g) 21.93 ± 0.06 
Total phenolic content  (mg GAE/g) 70.64 ± 0.11 
 
Effect of FHE on nipple height  
 
As shown in Table 2, the nipple height increased 
significantly in the model group compared with 
those in the control group (p < 0.05). Compared 
with model group, the middle-dose and high-
dose FHE as well as tamoxifen treatment 
significantly decreased breast nipple height (p < 
0.05). 
 
Table 2: Effect of FHE on breast nipple height in HMG 
rats after 4 weeks of administration (mean ± SEM, n = 
10) 
 
Group Dose Nipple height (mm) 
Control - 0.98± 0.11 
Model - 1.56 ± 0.12* 
Tamoxifen 1.65mg/kg 1.13 ± 0.12** 
FHE -L 150mg/kg 1.39± 0.16 
FHE -M 300mg/kg 1.12 ± 0.10** 
FHE -H 600mg/kg 1.05 ± 0.13** 
*P < 0.05 vs control group; **p < 0.05 vs. model group; 
model = HMG model rats 
 
Effect of FHE on serum MDA, SOD, GSH-Px 
and 5-HT 
 
As shown in Table 3, MDA concentration was 
significantly higher in the model than in the 
control rats (p < 0.01), but they were attenuated 
by middle-dose, high-dose treatment of FHE and 
tamoxifen groups (p < 0.05). SOD and GSH-Px 
concentrations were significantly lower in the 
model than in the sham-operated rats (p < 0.01), 
but they were increased in middle-dose and high-
dose treatment of FHE groups (p < 0.01). 
 
5-HT concentration was significantly higher in the 
model than in the sham-operated rats (p < 0.01), 
but was attenuated by middle-dose and high-
dose treatment of FHE (p < 0.01). 
 
Effect of FHE on serum E2, P, PRL, FSH, LH 
and GnRH 
 
As shown in Table 4, serum E2, PRL and FSH, 
GnRH concentrations were significantly higher in 
the model than in the control rats compared with 
model group, they were attenuated by middle-  
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    Table 3: Effect of FHE on serum MDA, SOD, GSH-Px and 5-HT levels in HMG rats (mean ± SEM, n = 10)  
  
MDA SOD GSH-Px 5-HT Group Dose (cB/(μmol/L) (λB/U/mg) (λB/104U/L) (pg/mL) 
Control –– 1.82 ± 0.25 208.49 ± 4.58 8.25 ± 0.24 17.292 ± 0.747 
Model –– 3.41 ± 0.43† 165.35 ± 5.12† 5.45 ± 0.36† 27.515 ±4.375†  
Tamoxifen  1.65 (mg/kg) 2.05 ± 0.46* 176.58 ± 6.91 6.94 ± 0.25* 25.714 ± 5.097 
FHE-L 150 (mg/kg) 2.61 ± 0.51 168.14 ± 5.55 5.82 ± 0.37  25.630 ± 3.844 
FHE-M 300 (mg/kg) 2.38 ± 0.36* 198.65 ± 2.85**  7.20 ± 0.32** 20.670 ± 2.636** 
FHE-H 600 (mg/kg)  2.19 ± 0.25* 206.21 ± 3.46**  8.67 ± 0.33** 18.179 ± 2.053**   
†p < 0.01 vs control group. * p < 0.05, ** p < 0.01 vs Model group; model = HMG model rats 
Table 4: Effect of FHE on E2, P, PRL, FSH, LH and GnRH in HMG rats (mean ± SEM, n = 10) 
 











Sham — 2.80 ± 0.34 1.41±0.16 286.37±7.08 0.08± 0.02 1.85± 0.10 1.26± 0.34 
Model — 4.85± 0.19† 0.63±0.06‡ 411.26±8.91‡ 0.52±0.01‡ 1.08± 0.05‡ 2.12 ± 0.10‡ 
Tamoxifen 1.65mg/kg 2.81 ± 0.28* 1.12±0.20* 414.29±15.24 0.48± 0.27 1.48± 0.10* 1.85 ± 0.12 
FHE-L 150mg/kg 3.58± 0.38 0.85±0.17 368.17±17.26 0.32± 0.01 1.15± 0.15 1.62 ± 0.39 
FHE-M 300mg/kg 2.97± 0.25* 1.03±0.18* 312.85±12.49* 0.18±0.02* 1.33± 0.10* 1.334± 0.32* 
FHE-H 600mg/kg 2.67± 0.16** 1.13±0.17* 278.93±8.42** 0.11±0.01** 1.77± 0.09* 1.27 ± 0.35** 
‡P < 0.05, †p < 0.01 vs control group; * p < 0.05, ** p < 0.01 vs model group; model = HMG model rats 
 
dose and high-dose treatment of FHE group. 
Serum P and LH concentrations were 
significantly lower in the model than in the control 
rats compared with model group, they were 
increased in middle-dose and high-dose 
treatment of FHE and tamoxifen group (p < 
0.05). 
 
Effect of FHE on morphology of mammary 
tissue 
 
The morphology of mammary tissue in control 
rats was shown in Figure 1A. Intense hyperplasia 
of gland alveolus and lobule, secretion, vessel 
arborization, lymphoplasia and plasma cells were 
observed in mammary gland tissues of HMG 
model rats (Figure 1B). In tamoxifen-treated rats 
at week 4, the hyperplasia of lobules and gland 
alveolus of mammary gland lessened, secretion 
and lymphocyte decreased in intracavitary 
(Figure 1C). The mammary gland of model rats 
treated with high-dose and middle-dose of FHE 
recovered well. There was few hyperplasia in 
gland alveolus and lobules of mammary gland, 
and only few secretion and lymphocyte was seen 
(Figure 1E and F). The low-dose of FHE had no 
significant effect, the gland alveolus, lobules 
hyperplasia and much secretion was still seen in 




Hypothalamus-pituitary-gonadal axis is one of 
the parts of NIM network and plays an important 
role in the maintenance of homeostasis of the 
internal environment and the normal 
physiological function of the organic body [17]. 
When extraneous stimulations act on human 
body, some sex hormones secrete abnormally 
leading to many kinds of disease such as HMG, 
hyperprolactinemia, hysteromyoma and infertility. 
The sex hormone disorder occurs in HMG rat 
models [18]. 
 
Our study result revealed that FHE regulated 
PRL, E2, P, FSH, LH and GnRH, and eliminated 
the hyperplasia of lobules and gland alveolus. 
FHE has therapeutic effects on HMG rats 
induced by estrogen and progestogen. It showed 
that E2, PRL, FSH and GnRH were remarkably 
decreased while P and LH concentrations 
significantly increased by FHE treatment 
compared with HMG model group. 
 
Histopathological examination revealed that FHE 
remarkably alleviated the degree of HMG, 
number of lobules and acinars. Therefore, the 
mechanism of FHE in treating HMG is by way of 
regulating endocrinal and immune functions to 
inhibit the pathological proliferation of mammary 
gland. 
 
MDA, SOD and GSH-Px are important indices 
reflecting antioxidant capacity in vivo. Estrogen 
plays an important role in HMG and breast 
carcinoma [19]. The results presented serum 
MDA concentration increased and SOD, GSH-Px 
concentrations decreased in model rats 
compared with control group. FHE decreased 
MDA level and increased SOD and GSH-Px 
levels significantly, revealing that FHE treated 
HMG by inhibiting lipid peroxidation to regulate 
free radical metabolism. Serum 5-HT concentra- 
Chen & Li 





Fig. 1: Effect of FHE on pathological morphology of mammary tissue (x200). A = control group; B = model group; 
C = Tamoxifen group; D = Low-dose of FHE group; E = Middle-dose of FHE group; F = High-dose of FHE group; 
HGA = hyperplasia of gland alveolus; S = secretion; L = lymphocyte; Model: HMG model rats 
 
tion increased significantly in HMG rats revealing 
that emotion and psychic factors play important 
roles in the occurrence of HMG. FHE decreased 
5-HT concentration effectively, suggesting the 
regulating action of traditional Chinese herb 
Fructus hordei G [20]. 
The total flavonoids, alkaloids and phenols are 
the main compositions of Fructus hordei G. 
extract, which contributed together to the 
antihyperplasia effect in rats. The mechanism 




The study showed that Fructus hordei G extract 
has significant antihyperplasia effect on mice 
mammary gland, and therefore has the potential 
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